In 2023, the average length of stay for leiomyoma of the uterus in French hospitals was approximately 2.6 days. Forecasted data indicates a decline in hospital stay durations from 2024 to 2028, with projected lengths of stay decreasing from 2.5 days in 2024 to 1.9 days by 2028. This represents a year-on-year reduction of around 8% in 2025 and a compounded annual growth rate (CAGR) of approximately -6.3% over the five-year period from 2024 to 2028.

Future trends to watch for include:

Continued advancements in minimally invasive surgical procedures, which may further reduce hospitalization times.
Improvements in outpatient care and postoperative management that can potentially lower the need for extended hospital stays.
Policies aimed at healthcare efficiency that could influence hospital practices and reduce lengths of stay.